2 by bolus route and then at the dose 20-30 mg/h for 1-3 days constantly as aerosol followed by extubation of patient. Method provides possibility of early softening ventilation indices, decrease of time for patient at the state of artificial lung ventilation up to 8-72 h, significant decrease of total course dose of surfactant and significant increase of viability of patients. Invention can be used for treatment of patients with respiratory insufficiency of II-III degree of severity. EFFECT: enhanced effectiveness of treatment. 1 tbl, 3 ex"/>
公开/公告号RU2149017C1
专利类型
公开/公告日2000-05-20
原文格式PDF
申请/专利号RU19990113398
申请日1999-07-01
分类号A61K38/00;A61K38/17;A61P11/00;
国家 RU
入库时间 2022-08-22 01:43:12